Can-Fite BioPharma Ltd. Total Current Liabilities 2011-2026 | CANF

Annual Total Current Liabilities Can-Fite BioPharma Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.05 M	2.02 M	2.5 M	2.73 M	1.27 M	3.27 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
3.27 M	1.27 M	2.31 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Current Liabilities	Price	% 24h	Market Cap	Country
Alector ALEC	69.5 M	$ 2.13	-12.55 %	$ 219 M	USA
Acer Therapeutics ACER	19 M	-	2.71 %	$ 14 M	USA
BioCardia BCDA	3.61 M	$ 1.37	6.2 %	$ 29 M	USA
Black Diamond Therapeutics BDTX	20.6 M	$ 2.4	-2.83 %	$ 132 M	USA
I-Mab IMAB	576 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.62 B	-	-	$ 40.3 B	USA
BioXcel Therapeutics BTAI	22.2 M	$ 1.64	-1.8 %	$ 4.16 M	USA
AgeX Therapeutics AGE	5.91 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	58.7 M	-	-	$ 1.01 B	USA
BeyondSpring BYSI	11 M	$ 1.44	6.3 %	$ 58.1 M	USA
Cabaletta Bio CABA	16 M	$ 3.34	0.6 %	$ 3.9 M	USA
AbCellera Biologics ABCL	64.3 M	$ 3.7	2.49 %	$ 1.11 B	Canada
Applied Genetic Technologies Corporation AGTC	25.2 M	-	-	$ 26.5 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	1.77 M	-	-1.52 %	$ 24.7 M	USA
Codexis CDXS	23.6 M	$ 1.05	3.47 %	$ 77.1 M	USA
Cerus Corporation CERS	63.6 M	$ 2.6	1.56 %	$ 480 M	USA
Certara CERT	153 M	$ 7.17	1.27 %	$ 1.15 B	USA
Cullinan Management CGEM	30.6 M	$ 15.91	2.65 %	$ 931 M	USA
Compugen Ltd. CGEN	20.2 M	$ 2.28	25.97 %	$ 204 M	Israel
ARCA biopharma ABIO	13 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	228 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	1.93 M	-	4.01 %	$ 150 M	Canada
Coherus BioSciences CHRS	332 M	$ 1.66	-0.9 %	$ 156 M	USA
Adverum Biotechnologies ADVM	22.9 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	556 M	-	-	-	Russia
AIkido Pharma AIKI	3.78 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	39.8 M	-	-	$ 3.67 B	USA
Akouos AKUS	16.8 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	45.3 M	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	15.7 M	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	5.75 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	5.24 M	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	58 M	-	-	$ 2.17 B	USA
Ampio Pharmaceuticals AMPE	2.38 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	15.1 M	-	-	$ 10.1 M	USA
CNS Pharmaceuticals CNSP	2.52 M	$ 3.1	-0.44 %	$ 1.18 M	USA
Aravive ARAV	22.1 M	-	-13.39 %	$ 1.45 M	USA
Cocrystal Pharma COCP	2.43 M	$ 1.02	-0.97 %	$ 10.4 M	USA
Aptose Biosciences APTO	4.46 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	6.29 M	-	-39.0 %	$ 4.57 M	USA
Collegium Pharmaceutical COLL	440 M	$ 42.0	0.79 %	$ 1.33 B	USA
Corcept Therapeutics Incorporated CORT	166 M	$ 35.61	-0.25 %	$ 3.7 B	USA
Athira Pharma ATHA	13.1 M	-	-	$ 269 M	USA
Aridis Pharmaceuticals ARDS	36.9 M	-	17.91 %	$ 11.1 M	USA